EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Evidence-Based Medicine 2007;12:107; doi:10.1136/ebm.12.4.107
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pitt, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pitt, B.

Therapeutics

Percutaneous coronary intervention plus optimal medical therapy was not more effective than medical therapy alone in stable CAD

Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503–16.[Abstract/Free Full Text]

Q In patients with stable coronary artery disease (CAD), is percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT) more effective for preventing cardiovascular events than OMT alone?

Clinical impact ratings GP/FP/Primary care ******* Internal medicine ******{star} Cardiology ******{star}

Key Words: angioplasty (transluminal, percutaneous coronary) • coronary disease • myocardial infarction

The first 150 words of the full text of this article appear below.

METHODS
Formula Design: randomised controlled trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial).

Formula Allocation: unclear allocation concealment.*

Formula Blinding: blinded (outcome adjudication committee).*

Formula Follow up period: median 4.6 years (range 2.5–7.0 y).

Formula Setting: 50 centres in the US and Canada.

Formula Patients: 2287 patients (mean age 62 y, 85% men) with stable CAD (stenosis >=70% in >=1 proximal epicardial coronary artery and objective evidence of myocardial ischaemia, or >=1 coronary stenosis >=80% and classic angina without provocative testing). Exclusion criteria included persistent class IV angina, a markedly positive stress test, refractory heart failure or cardiogenic shock, ejection fraction <30%, revascularisation in <=6 months, and coronary anatomy not suitable for PCI.

Formula Intervention: PCI (with bare metal stents in most patients) plus OMT (anti-ischaemic therapy, aggressive therapy to optimise lipid levels, and a lifestyle intervention) (n = 1149) or OMT alone (n = 1138).

Formula Outcomes: composite end point of death or non-fatal myocardial . . . [Full text of this article]

Bertram Pitt, MD

University of Michigan School of Medicine, Ann Arbor, Michigan, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.